Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Pharmacology & Therapeutics|August 24, 1999
Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitorsD W FryPharmacology & Therapeutics|October 1, 1991
Biochemical pharmacology of anthracenediones and anthrapyrazolesD W FryAnti-Cancer Drug Design|July 11, 2000
Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancerD W FryExperimental Cell Research|June 15, 1997
Cytoskeletal and morphological changes associated with the specific suppression of the epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid carcinomaJ M Nelson, D W FrySeminars in Oncology|November 14, 2001
Anticancer therapy targeting the erbB family of receptor tyrosine kinasesW J Slichenmyer, D W FryMolecular Pharmacology|January 1, 1988
Biochemical pharmacology and DNA-drug interactions by Cl-958, a new antitumor intercalator derived from a series of substituted 2H-[1]benzothiopyrano[4,3,2-cd]indazolesD W Fry, J A BessererCancer Biochemistry Biophysics|September 1, 1993
Expression of a 118 Kd protein in colon carcinoma cells that is immunologically related to PLC-gamma 1 and is augmented by serum-free conditionsD W Fry, L A AmbrosoThe Journal of Membrane Biology|January 1, 1982
Further studies on the charge-related alterations of methotrexate transport in Ehrlich ascites tumor cells by ionic liposomes: correlation with liposome-cell associationD W Fry, I D GoldmanCancer Metastasis Reviews|January 1, 1987
Biological and biochemical properties of new anticancer folate antagonistsD W Fry, R C JacksonPageof 9